These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23986579)

  • 1. Kaposi's sarcoma-associated herpesvirus encodes a mimic of cellular miR-23.
    Manzano M; Shamulailatpam P; Raja AN; Gottwein E
    J Virol; 2013 Nov; 87(21):11821-30. PubMed ID: 23986579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
    Liu X; Happel C; Ziegelbauer JM
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified Cross-Linking, Ligation, and Sequencing of Hybrids (qCLASH) Identifies Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Targets in Endothelial Cells.
    Gay LA; Sethuraman S; Thomas M; Turner PC; Renne R
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection.
    Serquiña AKP; Kambach DM; Sarker O; Ziegelbauer JM
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.
    Li W; Jia X; Shen C; Zhang M; Xu J; Shang Y; Zhu K; Hu M; Yan Q; Qin D; Lee MS; Zhu J; Lu H; Krueger BJ; Renne R; Gao SJ; Lu C
    Oncotarget; 2016 May; 7(22):32286-305. PubMed ID: 27058419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth analysis of Kaposi's sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery.
    Umbach JL; Cullen BR
    J Virol; 2010 Jan; 84(2):695-703. PubMed ID: 19889781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines.
    Gottwein E; Corcoran DL; Mukherjee N; Skalsky RL; Hafner M; Nusbaum JD; Shamulailatpam P; Love CL; Dave SS; Tuschl T; Ohler U; Cullen BR
    Cell Host Microbe; 2011 Nov; 10(5):515-26. PubMed ID: 22100165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
    Ramalingam D; Happel C; Ziegelbauer JM
    J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.
    Cai X; Lu S; Zhang Z; Gonzalez CM; Damania B; Cullen BR
    Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5570-5. PubMed ID: 15800047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.
    Haecker I; Gay LA; Yang Y; Hu J; Morse AM; McIntyre LM; Renne R
    PLoS Pathog; 2012; 8(8):e1002884. PubMed ID: 22927820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A KSHV microRNA Directly Targets G Protein-Coupled Receptor Kinase 2 to Promote the Migration and Invasion of Endothelial Cells by Inducing CXCR2 and Activating AKT Signaling.
    Hu M; Wang C; Li W; Lu W; Bai Z; Qin D; Yan Q; Zhu J; Krueger BJ; Renne R; Gao SJ; Lu C
    PLoS Pathog; 2015 Sep; 11(9):e1005171. PubMed ID: 26402907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway.
    Lu F; Stedman W; Yousef M; Renne R; Lieberman PM
    J Virol; 2010 Mar; 84(6):2697-706. PubMed ID: 20071580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs and their roles in KSHV pathogenesis.
    Hussein HAM; Alfhili MA; Pakala P; Simon S; Hussain J; McCubrey JA; Akula SM
    Virus Res; 2019 Jun; 266():15-24. PubMed ID: 30951791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Encodes a Mimic of the Tumor-Suppressive miR-15/16 miRNA Family.
    Morrison K; Manzano M; Chung K; Schipma MJ; Bartom ET; Gottwein E
    Cell Rep; 2019 Dec; 29(10):2961-2969.e6. PubMed ID: 31801064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155.
    Skalsky RL; Samols MA; Plaisance KB; Boss IW; Riva A; Lopez MC; Baker HV; Renne R
    J Virol; 2007 Dec; 81(23):12836-45. PubMed ID: 17881434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the mRNA targetome of microRNAs expressed by Marek's disease virus.
    Parnas O; Corcoran DL; Cullen BR
    mBio; 2014 Jan; 5(1):e01060-13. PubMed ID: 24449754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle.
    Lu CC; Li Z; Chu CY; Feng J; Feng J; Sun R; Rana TM
    EMBO Rep; 2010 Oct; 11(10):784-90. PubMed ID: 20847741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small RNA profiling reveals antisense transcription throughout the KSHV genome and novel small RNAs.
    Lin YT; Kincaid RP; Arasappan D; Dowd SE; Hunicke-Smith SP; Sullivan CS
    RNA; 2010 Aug; 16(8):1540-58. PubMed ID: 20566670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KSHV microRNAs: Tricks of the Devil.
    Qin J; Li W; Gao SJ; Lu C
    Trends Microbiol; 2017 Aug; 25(8):648-661. PubMed ID: 28259385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice.
    Boss IW; Nadeau PE; Abbott JR; Yang Y; Mergia A; Renne R
    J Virol; 2011 Oct; 85(19):9877-86. PubMed ID: 21813606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.